Mimedx (MDXG) Total Non-Current Liabilities (2010 - 2026)

Mimedx has disclosed Total Non-Current Liabilities across 17 years of filings, most recently posting $60.6 million for Q1 2026.

• Total Non-Current Liabilities for Q1 2026 came in at $60.6 million, up 0.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $60.6 million (up 0.82% YoY), and the FY2025 annual result was $80.7 million, up 27.29% from the prior year.
• Total Non-Current Liabilities came in at $60.6 million for Q1 2026 at Mimedx, down from $80.7 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $94.3 million in Q3 2022 to a low of $58.3 million in Q2 2024.
• The 5-year median for Total Non-Current Liabilities is $80.7 million (2025), against an average of $77.2 million.
• Across the five-year window, Total Non-Current Liabilities slumped 37.55% in 2024 and gained 27.29% in 2025, its largest moves.
• Mimedx's Total Non-Current Liabilities stood at $92.2 million in 2022, then grew by 2.12% to $94.1 million in 2023, then tumbled by 32.6% to $63.4 million in 2024, then rose by 27.29% to $80.7 million in 2025, then declined by 24.88% to $60.6 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $60.6 million (Q1 2026), $80.7 million (Q4 2025), and $74.5 million (Q3 2025), per Business Quant data.